Five researchers at the Johns Hopkins Applied Physics Laboratory (APL) received the APL invention of the year award for their device that can rapidly identify whether microbial pathogens are resistant to antibiotics. The prototype isoMS-drug-array depends on proprietary algorithms to interpret results of stable isotope mass spectrometry (MS) analyses. Once refined, this analytic package could be used for forensic purposes in homeland defense settings, in clinical microbiology laboratories, and for research and development of antimicrobial drugs, according to Plamen Demirev of APL and his fellow awardees Miquel
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The isoMS-drug-array prototype builds on several earlier APL developments, particularly the chemicalbiological, time-of-flight (CB-TOF) system that analyzes suspicious "white powders" to determine whether they contain Bacillus anthracis spores. This earlier analytic system was developed for the U.S. Department of Homeland Security, Demirev notes.
The newer isoMS-drug-array analysis begins with investigators growing an unidentified microorganism in a medium that is enriched with nutrients containing the nonradioactive isotope carbon-13, according to Demirev. As the bacteria grow, they incorporate the heavier isotope into any carboncontaining molecules being synthesized, leading to a shift in molecular mass.
"If we observe such a shift when examining a microorganism in a labeled medium when a drug is present, this means that the drug is not affecting the growth of that microorganism," Demirev says. Meanwhile, the matrix-assisted laser desorptionionization (MALDI)-MS signature can be used to identify a broad variety of biological agents, including viruses, bacteria, spores, and fungi, Demirev points out. The TOF for each ion correlates with its mass, resulting in a characteristic mass spectrum for each organism.
"Let's say you have Bacillus spores," Demirev says. "The identification can be done directly within 30 minutes using our technology that includes hardware, protocols, and algorithms, based on predicted and observed signatures for Bacillus spores. At the same time, with part of the sample one can start the growth protocol and within five hours we can confirm (or refute) the identification, depending on whether we observe the predicted signature for the vegetative cells."
"The novelty and innovation of this technology lies not so much in its ability to rapidly identify unknown microorganisms, but rather in its ability to rapidly determine whether an unknown or uncharacterized microbe is antibiotic resistant," says Todd Sandrin of Arizona State University in Phoenix, who also uses MALDI-TOF to fingerprint bacterial species, including Escherichia coli and Enterococcus. Describing the use of stable isotopes to determine antibiotic resistance "intriguing," he says that the APL approach could face "more limited utility" when it comes to analyzing "slowly growing and difficult-toculture microorganisms."
The unit cost for each isoMS-drugarray test could be as low as $10, according to Demirev. However, that unit estimate comes after an initial investment of as much as $175,000 for a suite of instruments, including a commercial MS, APL-designed hardware, an automated prep station, protocols, and software.
This analytic system could also be mounted inside a vehicle for a firstresponse team to use on site. However, the next phase of development will depend on the APL Technology Transfer Office finding an appropriate partner in the private sector. Chaotropes comprise a diverse set of structurally disruptive compounds that includes ethanol, urea, fructose, salts such as magnesium chloride, and aromatic agents such as phenol. They work by interfering with noncovalent bonds and find use in labs during purifications and analyses of macromolecules.
At lower temperatures, because chaotropes disrupt noncovalent interactions among macromolecules, their presence tends to enliven metabolic activities that would otherwise remain sluggish. For example, sea-ice algae withstand Ϫ20°C and very high levels of sodium chloride, according to microbial ecologist Graham Underwood of the University of Essex in Essex, England.
Cold can be a double whammy for prokaryotes, Hallsworth says. Although high solute concentrations keep water from freezing once it reaches 0°C, high solute itself is exceptionally stressful to microbes. Chaotropes, however, can loosen cellular structures that ordinarily stiffen with falling temperatures. "I wondered whether and how such cells would be able to use the solute activities of environmental substances or their own metabolites to enhance their metabolic activities at otherwise prohibitively low temperatures, he says.
Hallsworth, Underwood, and their collaborators screened cold-tolerant algae, fungi, and bacteria for solute tolerance, screened a set of 161 solutetolerant fungi for low-temperature tolerance, and then cultured the microbes with the highest combined solute-and-low-temperature tolerance on growth media supplemented either with chaotropes or with their functional opposites, macromoleculestabilizing compounds, called kosmotropes.
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